# Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II

Source: https://onco.cc/trials/nct07649980/  
OnCo record `nct07649980` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of pucotenlimab in gallbladder cancer and other biliary tract cancers, run by HuiKai Li, not yet recruiting.

## Summary

Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II is a phase 2 interventional study registered as NCT07649980 by HuiKai Li, with a registry enrolment figure of 30 participants, started 2026-07-01 and due to reach its primary completion in 2029-07-01. Interventions recorded: Becotatug Vedotin, Pucotenlimab. Conditions listed: Biliary Tract Cancer (BTC), EGFR-positive Advanced Biliary Tract Carcinoma. Gallbladder cancer is named in the registry entry: "2. Histologically or cytologically confirmed advanced biliary tract cancer (BTC), including intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (ECC), and gallbladder cancer (GBC); recurrent biliary tr". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07649980
- Phase: 2
- Setting: Becotatug Vedotin Combined With Pucotenlimab in First-Line Treatment-Failed Advanced Biliary Tract Carcinoma: A Phase II Exploratory Clinical Study
- Sponsor: HuiKai Li
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT07649980: https://clinicaltrials.gov/study/NCT07649980

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Extrahepatic cholangiocarcinoma (perihilar and distal)](https://onco.cc/cancers/extrahepatic-cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/), [Intrahepatic cholangiocarcinoma](https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- drugs: [Pucotenlimab](https://onco.cc/drugs/pucotenlimab/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07649980.json